AI assistant
Sending…
LAM RESEARCH CORP — Director's Dealing 2017
Feb 16, 2017
29803_dirs_2017-02-16_3e55e219-da0a-42e4-ab8f-933982f32d7c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LAM RESEARCH CORP (LRCX)
CIK: 0000707549
Period of Report: 2017-02-14
Reporting Person: ARCHER TIMOTHY (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-14 | Common Stock | M | 20000 | $29.34 | Acquired | 93263 | Direct |
| 2017-02-14 | Common Stock | S | 11361 | $115.47 | Disposed | 81902 | Direct |
| 2017-02-14 | Common Stock | S | 8639 | $115.81 | Disposed | 73263 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-02-14 | Employee Stock Option (Right to Buy) | $29.34 | M | 20000 | Disposed | 2020-12-16 | Common Stock (20000.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4385 | Indirect |
| Common Stock | 518 | Indirect |
Footnotes
F1: Shares exercised pursuant to 10b5-1 Trading Plan
F2: Amount reported includes shares subject to unvested Restricted Stock Units.
F3: Shares sold pursuant to 10b5-1 Trading Plan.
F4: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $114.70 to $115.69, inclusive.
F5: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $115.70 to $115.95, inclusive.
More from LAM RESEARCH CORP
Regulatory Filings
2026
Jun 1
Major Shareholding Notification
2026
Apr 30
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 22
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3